Aging Rewrites the Brain’s Protein Code – and Scientists Just Found the Switch

Age-related changes in protein tagging and degradation may help explain how the brain declines over time and why diet can ...
Knowridge Science Report

Poor kidney function may skew Alzheimer’s blood test results, study warns

People with reduced kidney function may have higher levels of several blood markers commonly used in Alzheimer’s disease ...
Healio

Population-based eGFR data may help identify patients at risk for kidney failure earlier

Identifying population-based eGFR distributions may help to identify patients at risk for developing chronic kidney disease earlier, according to study data published in Kidney International. More ...
BioSpace

All Eyes on Vertex’s Kidney Franchise, as Painkiller Journavx Tops Half a Million Scripts

Analysts are keeping a close eye on Vertex’s kidney disease portfolio, anchored by the IgAN drug povetacicept, as its nonopioid painkiller Journavx is poised for “incremental” growth in the first half ...

Novartis says conditionally approved kidney drug shows long-term promise

On Friday, Novartis AG NVS shared final results from the Phase 3 ALIGN study supporting a slowing decline in kidney function in adults with IgA nephropathy (IgAN) who were treated with Vanrafia ...
EuropaWire

Novartis Reports Final Phase III ALIGN Results Supporting Kidney Function Benefit of Vanrafia in IgA Nephropathy

(PRESS RELEASE) BASEL, 13-Feb-2026 — / EuropaWire / — Novartis has announced final Phase III results from the ALIGN study evaluating Vanrafia (atrasentan) in adults with IgA nephropathy (IgAN), ...
Medscape

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.
Investing.com UK

Novartis says Vanrafia slows kidney function decline in IgAN patients

Investing.com -- Novartis announced Friday that its drug Vanrafia has demonstrated effectiveness in slowing the decline of kidney function in adults with IgA nephropathy (IgAN), a progressive ...

Novartis Says Vanrafia Drug Slows Kidney Function Decline

Novartis said its Vanrafia drug slows the decline in kidney function for adults with the progressive autoimmune kidney ...

Novartis Pharma AG: Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...
The Manila Times

Novartis Vanrafia® Phase III data support slowing of kidney function decline in patients with IgA nephropathy

In ALIGN study, Vanrafia (atrasentan) showed positive differencein eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...

Fast-aging fish reveals how kidneys age and how a common drug protects them

Kidney aging rarely draws attention until something goes wrong. Over time, these organs quietly lose strength, filter less efficiently, and struggle to keep the body balanced.